Form 4 for EYPT EyePoint, Inc.

Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001562180-22-001410 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-02-11	2022-02-09	EYPT	Lurker Nancy	Pres, CEO, Dir	M - OptEx	$0.00	+17.5K	124.1K	+16%	$0
D	2022-02-11	2022-02-09	EYPT	Lurker Nancy	Pres, CEO, Dir	M - OptEx	$0.00	-17.5K	35.1K	-33%	$0
DM	2022-02-11	2022-02-09	EYPT	Lurker Nancy	Pres, CEO, Dir	A - Grant	$0.00	+300.0K	240.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-09	M	A	17,533	$0.00	124,098	D	—	—	(F1) Includes 3,019 shares acquired on January 31, 2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
2	Derivative	Restricted Stock Units	2022-02-09	M	D	17,533	$0.00	35,067	D	$0.00 · — to —	17,533 Common Stock	(F2) The restricted stock units vest in three ratable annual installments beginning February 9, 2022.
3	Derivative	Restricted Stock Units	2022-02-09	A	A	60,000	$0.00	60,000	D	$0.00 · — to —	60,000 Common Stock	(F3) These restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
4	Derivative	Stock Option (Right to Buy)	2022-02-09	A	A	240,000	$0.00	240,000	D	$10.13 · — to 2032-02-09	240,000 Common Stock	(F4) The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years.